Annual Working Capital
$18.28 M
-$37.37 M-67.15%
31 December 2023
Summary:
Akebia Therapeutics annual working capital is currently $18.28 million, with the most recent change of -$37.37 million (-67.15%) on 31 December 2023. During the last 3 years, it has fallen by -$166.01 million (-90.08%). AKBA annual working capital is now -91.59% below its all-time high of $217.25 million, reached on 31 December 2017.AKBA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$34.41 M
+$29.61 M+617.34%
30 September 2024
Summary:
Akebia Therapeutics quarterly working capital is currently $34.41 million, with the most recent change of +$29.61 million (+617.34%) on 30 September 2024. Over the past year, it has increased by +$4.51 million (+15.09%). AKBA quarterly working capital is now -87.95% below its all-time high of $285.56 million, reached on 31 March 2018.AKBA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AKBA Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -67.2% | +15.1% |
| 3 y3 years | -90.1% | -75.6% |
| 5 y5 years | -91.0% | -54.6% |
AKBA Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -90.1% | +81.0% | -75.6% | +617.3% |
| 5 y | 5 years | -91.0% | +81.0% | -86.4% | +617.3% |
| alltime | all time | -91.6% | +782.2% | -88.0% | +617.3% |
Akebia Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.41 M(+617.3%) |
| June 2024 | - | $4.80 M(-89.7%) |
| Mar 2024 | - | $46.46 M(+154.2%) |
| Dec 2023 | $18.28 M(-67.2%) | $18.28 M(-38.9%) |
| Sept 2023 | - | $29.90 M(+13.8%) |
| June 2023 | - | $26.26 M(-30.5%) |
| Mar 2023 | - | $37.77 M(-32.1%) |
| Dec 2022 | $55.65 M(+451.1%) | $55.65 M(+12.3%) |
| Sept 2022 | - | $49.55 M(-29.7%) |
| June 2022 | - | $70.48 M(+44.5%) |
| Mar 2022 | - | $48.77 M(+383.0%) |
| Dec 2021 | $10.10 M(-94.5%) | $10.10 M(-92.8%) |
| Sept 2021 | - | $140.88 M(-14.9%) |
| June 2021 | - | $165.48 M(-14.0%) |
| Mar 2021 | - | $192.34 M(+4.4%) |
| Dec 2020 | $184.29 M(+81.7%) | $184.29 M(-12.1%) |
| Sept 2020 | - | $209.54 M(-17.3%) |
| June 2020 | - | $253.33 M(+100.1%) |
| Mar 2020 | - | $126.60 M(+24.8%) |
| Dec 2019 | $101.42 M | $101.42 M(+33.7%) |
| Sept 2019 | - | $75.86 M(-42.0%) |
| June 2019 | - | $130.78 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $144.62 M(-28.6%) |
| Dec 2018 | $202.58 M(-6.8%) | $202.58 M(-8.0%) |
| Sept 2018 | - | $220.13 M(-9.4%) |
| June 2018 | - | $243.00 M(-14.9%) |
| Mar 2018 | - | $285.56 M(+31.4%) |
| Dec 2017 | $217.25 M(+19.3%) | $217.25 M(+19.0%) |
| Sept 2017 | - | $182.58 M(+21.1%) |
| June 2017 | - | $150.80 M(+24.0%) |
| Mar 2017 | - | $121.59 M(-33.2%) |
| Dec 2016 | $182.05 M(+41.0%) | $182.05 M(+31.0%) |
| Sept 2016 | - | $139.01 M(-19.0%) |
| June 2016 | - | $171.59 M(-16.8%) |
| Mar 2016 | - | $206.12 M(+59.6%) |
| Dec 2015 | $129.15 M(+24.7%) | $129.15 M(-10.7%) |
| Sept 2015 | - | $144.64 M(-3.0%) |
| June 2015 | - | $149.06 M(+58.8%) |
| Mar 2015 | - | $93.85 M(-9.4%) |
| Dec 2014 | $103.59 M(+250.8%) | $103.59 M(-8.6%) |
| Sept 2014 | - | $113.32 M(-6.6%) |
| June 2014 | - | $121.28 M(-5.0%) |
| Mar 2014 | - | $127.62 M(+332.2%) |
| Dec 2013 | $29.53 M(-1202.1%) | $29.53 M |
| Dec 2012 | -$2.68 M | - |
FAQ
- What is Akebia Therapeutics annual working capital?
- What is the all time high annual working capital for Akebia Therapeutics?
- What is Akebia Therapeutics annual working capital year-on-year change?
- What is Akebia Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Akebia Therapeutics?
- What is Akebia Therapeutics quarterly working capital year-on-year change?
What is Akebia Therapeutics annual working capital?
The current annual working capital of AKBA is $18.28 M
What is the all time high annual working capital for Akebia Therapeutics?
Akebia Therapeutics all-time high annual working capital is $217.25 M
What is Akebia Therapeutics annual working capital year-on-year change?
Over the past year, AKBA annual working capital has changed by -$37.37 M (-67.15%)
What is Akebia Therapeutics quarterly working capital?
The current quarterly working capital of AKBA is $34.41 M
What is the all time high quarterly working capital for Akebia Therapeutics?
Akebia Therapeutics all-time high quarterly working capital is $285.56 M
What is Akebia Therapeutics quarterly working capital year-on-year change?
Over the past year, AKBA quarterly working capital has changed by +$4.51 M (+15.09%)